Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AAGR NASDAQ:NOVS NASDAQ:XXII NASDAQ:YTEN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAAGRAfrican Agriculture$0.01+1.0%$0.01$0.00▼$0.19$94K-14.241,586 shs101 shsNOVSNovus Capital$28.63$9.61▼$28.98$842KN/A370,842 shs10.17 million shsXXII22nd Century Group$4.75-7.6%$15.02$4.70▼$2,837.04$2.60M1.7830,786 shs99,075 shsYTENYield10 Bioscience$0.02$0.31▼$17.26$257K1.4878,164 shsN/A7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAAGRAfrican Agriculture+1.01%0.00%-33.33%+25.00%-94.15%NOVSNovus Capital0.00%0.00%0.00%0.00%0.00%XXII22nd Century Group-7.59%-19.76%-68.03%-72.75%-99.82%YTENYield10 Bioscience0.00%0.00%0.00%0.00%-98.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAAGRAfrican AgricultureN/AN/AN/AN/AN/AN/AN/AN/ANOVSNovus CapitalN/AN/AN/AN/AN/AN/AN/AN/AXXII22nd Century Group0.6246 of 5 stars0.03.00.00.03.00.00.6YTENYield10 BioscienceN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAAGRAfrican Agriculture 0.00N/AN/AN/ANOVSNovus Capital 0.00N/AN/AN/AXXII22nd Century Group 0.00N/AN/AN/AYTENYield10 Bioscience 0.00N/AN/AN/ALatest NOVS, YTEN, AAGR, and XXII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/12/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)6/27/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)6/11/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)5/24/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)5/10/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)4/24/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAAGRAfrican Agriculture$1.75M0.05N/AN/A($2.39) per share0.00NOVSNovus CapitalN/AN/AN/AN/AN/AN/AXXII22nd Century Group$11.07M0.22N/AN/A$53.71 per share0.09YTENYield10 Bioscience$60K0.00N/AN/A($4.97) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAAGRAfrican Agriculture-$43.06MN/A0.00∞N/AN/AN/AN/AN/ANOVSNovus CapitalN/AN/A0.00N/AN/AN/AN/AN/AN/AXXII22nd Century Group-$15.16M-$2,986.49N/A∞N/A-57.62%-524.68%-57.04%8/12/2025 (Estimated)YTENYield10 Bioscience-$14.45M-$26.12N/AN/AN/AN/AN/A-296.08%8/12/2025 (Estimated)Latest NOVS, YTEN, AAGR, and XXII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025XXII22nd Century Group-$0.27N/AN/AN/AN/AN/A5/13/2025Q1 2025XXII22nd Century Group-$25.30-$43.47-$18.17-$2.50$4.70 million$5.96 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAAGRAfrican AgricultureN/AN/AN/AN/AN/ANOVSNovus CapitalN/AN/AN/AN/AN/AXXII22nd Century GroupN/AN/AN/AN/AN/AYTENYield10 BioscienceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAAGRAfrican AgricultureN/AN/AN/ANOVSNovus CapitalN/A10.4810.48XXII22nd Century GroupN/A0.680.52YTENYield10 BioscienceN/A0.160.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAAGRAfrican Agriculture20.52%NOVSNovus Capital43.82%XXII22nd Century Group18.06%YTENYield10 Bioscience4.91%Insider OwnershipCompanyInsider OwnershipAAGRAfrican Agriculture48.40%NOVSNovus CapitalN/AXXII22nd Century Group0.01%YTENYield10 Bioscience6.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAAGRAfrican Agriculture859.44 million4.87 millionNo DataNOVSNovus CapitalN/A12.65 millionN/ANot OptionableXXII22nd Century Group80506,000506,000OptionableYTENYield10 Bioscience30734,000689,000Not OptionableNOVS, YTEN, AAGR, and XXII HeadlinesRecent News About These CompaniesYield10 Bioscience Files for Chapter 11 BankruptcyDecember 6, 2024 | tipranks.comYield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key ProposalsNovember 8, 2024 | accesswire.comAYield10 Bioscience (OTC:YTEN) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comYield10 Bioscience (OTC:YTEN) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comYield10 Bioscience, Inc.: Yield10 Bioscience Announces Second Quarter 2024 Financial ResultsAugust 15, 2024 | finanznachrichten.deYield10 Bioscience Announces Second Quarter 2024 Financial ResultsAugust 14, 2024 | globenewswire.comNufarm buys Yield10’s camelina sativa investmentJuly 19, 2024 | graincentral.comGYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 17, 2024 | globenewswire.comYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 17, 2024 | globenewswire.comRothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in CamelinaJune 17, 2024 | globenewswire.comYield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide LabelMay 23, 2024 | globenewswire.comHold Rating on Yield10 Bioscience Amid Commercialization Challenges and Financial UncertaintiesMay 22, 2024 | markets.businessinsider.comYTEN Stock Earnings: Yield10 Bioscience Misses EPS, Misses Revenue for Q1 2024May 16, 2024 | investorplace.comYield10 Bioscience Shares Plumb New Depths After Nasdaq DelistingMay 15, 2024 | marketwatch.comYield10 Bioscience Announces First Quarter 2024 Financial ResultsMay 15, 2024 | globenewswire.comYield10 Bioscience Announces Delisting from NasdaqMay 15, 2024 | globenewswire.comYield10 Bioscience Sets 1-for-24 Reverse Stock SplitMay 1, 2024 | markets.businessinsider.comYield10 Bioscience to implement reverse stock splitMay 1, 2024 | msn.comYield10 Bioscience Announces 1-for-24 Reverse Stock SplitMay 1, 2024 | globenewswire.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call TranscriptApril 5, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNOVS, YTEN, AAGR, and XXII Company DescriptionsAfrican Agriculture NASDAQ:AAGR$0.01 +0.00 (+1.01%) As of 07/15/2025 09:54 AM EasternAfrican Agriculture Holdings Inc., through its subsidiary Les Fermes de la Teranga SA, develops commercial farming business focusing on the production and sale of alfalfa for cattle feed and nutrition purposes in Africa. The company is based in New York, New York. African Agriculture Holdings Inc. is a subsidiary of Global Commodities & Investments Ltd.Novus Capital NASDAQ:NOVSNovus Capital Corporation is a blank check company. The company was founded in 2020 and is based in Indianapolis, Indiana.22nd Century Group NASDAQ:XXII$4.75 -0.39 (-7.59%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$4.58 -0.17 (-3.58%) As of 07/15/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.Yield10 Bioscience NASDAQ:YTENYield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Fastenal Surges After Earnings Beat, Tariff Risks Loom Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
